Table 2 The percentage of hypermethylated or hypomethylated differentially methylated cytosines (DMC) in each or the annotated region.

From: Fibroblasts derived from oesophageal adenocarcinoma differ in DNA methylation profile from normal oesophageal fibroblasts

 

Hypermethylated (%)

Hypomethylated (%)

Total

OR (95% CI)

p-value

Total

1,613 (33.2%)

3,243 (66.8%)

4,856

  

Gene Regions

TSS1500

237 (34.8%)

445 (65.2%)

682

1.083 (0.9133–1.284)

0.3823

TSS200

86 (44.8%)

106 (55.2%)

192

16.78 (13.59–20.72)

<0.0001

5′UTR

166 (34.0%)

322 (66.0%)

488

1.041 (0.8540–1.268)

0.7302

1st Exon

39 (33.3%)

78 (66.7%)

117

1.005 (0.6813–1.484)

0.9424

Gene body

705 (36.1%)

1,249 (63.9%)

1,954

0.7294 (0.6510–0.8173)

<0.0001

3′UTR

77 (44.5%)

96 (55.5%)

173

1.643 (1.210–2.232)

0.0018

Intragenic

468 (27.6%)

1,228 (72.4%)

1,696

0.6707 (0.5896–0.7629)

<0.0001

CpG Island Regions

CGI

270 (59.6%)

183 (40.3%)

453

1.954 (1.790–2.134)

<0.0001

Shores

489 (40.5%)

719 (59.5%)

1,208

1.314 (1.208–1.429)

<0.0001

Shelves

138 (28.3%)

350 (71.7%)

488

0.8374 (0.7227–0.9703)

<0.0001

Open sea

716 (26.4%)

1,991 (73.6%)

2,707

0.6337 (0.5848–0.6866)

<0.0001

Enhancer Regions

Non-enhancer

976 (37.4%)

1,632 (62.6%)

2,608

  

Enhancer

637 (28.3%)

1,611 (71.7%)

2,248

0.6612 (0.5856–0.7464)

<0.0001